Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Terzolo

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Journal of Endocrinological Investigation|April 24, 2012
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinomaA Ferrero, P Sperone, A Ardito, et al.
Journal of Endocrinological Investigation|December 24, 2015
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?F Porpiglia, C Fiori, F C Daffara, et al.
European Journal of Endocrinology|May 8, 2014
Surgical remission of Cushing's syndrome reduces cardiovascular riskM Terzolo, B Allasino, A Pia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upM Fassnacht, G Assie, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]M Fassnacht, G Assie, E Baudin, et al.
European Journal of Endocrinology|September 9, 2015
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinomaA Ardito, C Massaglia, E Pelosi, et al.
Journal of Endocrinological Investigation|May 16, 2006
Prevalence of adrenal incidentaloma in a contemporary computerized tomography seriesS Bovio, A Cataldi, G Reimondo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
European Journal of Endocrinology|April 17, 2019
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrenceA Calabrese, V Basile, S Puglisi, et al.
Journal of Endocrinological Investigation|August 12, 2020
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life studyS Puglisi, A Rossini, I Tabaro, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Journal of Endocrinological Investigation|April 24, 2012
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinomaA Ferrero, P Sperone, A Ardito, et al.
Journal of Endocrinological Investigation|December 24, 2015
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?F Porpiglia, C Fiori, F C Daffara, et al.
European Journal of Endocrinology|May 8, 2014
Surgical remission of Cushing's syndrome reduces cardiovascular riskM Terzolo, B Allasino, A Pia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upM Fassnacht, G Assie, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]M Fassnacht, G Assie, E Baudin, et al.
European Journal of Endocrinology|September 9, 2015
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinomaA Ardito, C Massaglia, E Pelosi, et al.
Journal of Endocrinological Investigation|May 16, 2006
Prevalence of adrenal incidentaloma in a contemporary computerized tomography seriesS Bovio, A Cataldi, G Reimondo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
European Journal of Endocrinology|April 17, 2019
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrenceA Calabrese, V Basile, S Puglisi, et al.
Journal of Endocrinological Investigation|August 12, 2020
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life studyS Puglisi, A Rossini, I Tabaro, et al.
Pageof 11